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LIMITING THE TRANSMISSION OF LEPTOSPIROSIS TO HUMANS 
CATHERINE CARCHEDI 
 
ABSTRACT 
 
 Leptospirosis, a zoonotic disease, is transferable through wild animals to other 
animals and humans directly and indirectly through contact with urine on mucous 
membranes. This disease can pose hazards for humans because of their increased contact 
with wild animals through increased urbanization and greater wildlife rehabilitation 
efforts and also through increased contact with domesticated animals. Furthermore, 
humans also have the potential of contracting this potentially fatal disease through 
recreational activities in contaminated waters or soils. The disease can present itself 
mildly, similar to symptoms of the flu, or more severely, leading to end-organ damage of 
multiple systems.  
 Having been reinstated as a nationally notifiable disease by the Centers for 
Disease Control and Prevention in January 2013, leptospirosis has been recognized as a 
re-emerging zoonosis that has global public health implications. Understanding the 
disease is important in limiting its transmission; thus, this thesis aims to provide a review 
of the biology and transmission of leptospirosis to animals and humans, providing a basis 
in understanding the possible ways to limit the transmission and prevent future outbreaks. 
Furthermore, this thesis describes the manifestations, diagnostic testing, and treatment 
options for leptospirosis in canines and humans, as the increased prevalence of canines in 
households may pose a risk to humans in the future in the transmission of leptospirosis. 
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 According to current research, leptospires are extremely viable bacteria that can 
survive for long periods of time in a variety of environments and host species. 
Researchers have conducted various experiments to evaluate the factors that increase the 
virulence of leptospires. Experiments include the osmolarity, presence of serum, 
temperature chances, and the presence of iron. Results demonstrate that virulence 
increases with increased osmolarity, presence of serum, increased temperature, and the 
presence of iron. These characteristics of pathogenic leptospires allow them to avoid 
destruction by the immune system and colonize in the host, specifically in the renal 
tubules, allowing for excretion into the environment.  
  Limiting the transmission of the disease is very important to prevent future 
outbreaks for animal species and humans. One method of limiting this transmission 
includes the use of vaccines. A major issue is the transmission of disease surround renal 
shedding, or excretion of the bacteria in urine. Canine polyvalent vaccines, containing 
multiple serovars, have been proven to be effective for a year, providing immunity and 
decreasing renal shedding of the bacteria. While vaccines for humans have been 
developed, they are not widely used due to the variation of serovars that are able to infect 
humans around the world and also the geographic distribution of disease, with prevalence 
mainly in tropical regions.  
 Since leptospirosis is a disease that is not well-known, but can be found globally, 
there is necessity for greater emphasis on education, improved diagnostic testing, and 
treatment regimens. Emphasis on education is not only important for future veterinarians 
but also for those working in at-risk occupations. Furthermore, since experiments have 
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shown that pet owners may not be aware of the prevalence and danger of zoonotic 
diseases, veterinarians should provide education for pet owners as well. Currently, the 
disease is underreported, which is accounted for due to the currently used diagnostic 
methods that are not efficient for early diagnosis, such as microscopic agglutination test, 
polymerase chain reaction, and cultures. In regards to treatment, antimicrobial treatment 
is considered controversial and there is not an agreed upon method of treatment. Thus, an 
emphasis should be placed on a developing a treatment method that is able to directly 
affect leptospires and usable across varying populations.   
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INTRODUCTION 
 
 According to the World Health Organization (WHO), a zoonotic disease is an 
infection that is transmittable between vertebrate animals and humans. Zoonotic diseases 
produce public health issues in all regions of the world, particularly in underdeveloped 
regions (Meredith, 2011). In North America alone, more than 4 million people have been 
known to become infected each year (Meredith, 2011). Zoonotic diseases, transmitted 
from wildlife and domestic pets, accounts for 75% of human disease (Taylor, Latham, & 
Woolhouse, 2001).  More recently, with 62% of households in the United States having 
pets, zoonotic diseases, those that can be spread from animals to humans, have become 
more prevalent; however, pet owners often are unaware of the risks (Sandhu and Singh, 
2014). One such zoonotic disease, leptospirosis, has become an increasingly greater 
public health issue with a worldwide distribution and more than 1 million severe cases 
occurring annually, with mortality rates surpassing 10% (Adler, Lo, Seemann, & Murray, 
2011). However, many incidences of leptospirosis are unaccounted for because it is 
disease that is not only difficult to diagnose but often misdiagnosed (Levett, 2001). 
 There are many factors that determine the prevalence and distribution of 
leptospirosis (Plank & Dean, 2000). Leptospirosis has the highest prevalence rates in 
developing countries with tropical climates, where there is a rise in population size, urban 
decay, and increased rainfall (Plank & Dean, 2000). According to Hartskeerl, Collares-
Pereira, & Ellis (2011), leptospirosis is reemerging around the world, with the most 
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recent epidemics having occurred in Nicaragua in 2007, Sri Lanka in 2008, and the 
Philippines in 2009; however, the exact increase of leptospirosis remains unclear due to 
the lack of awareness, underreporting, lack of proper diagnostics and overall lack of 
biomedical research on transmission and treatment options. In the United States, 
leptospirosis has the highest incidence in Hawaii, due to the tropical climate (Levett, 
2001).  
 Leptospirosis is a disease caused by the Leptospira bacteria, which has 250 
variations, with the most well-known strains being icterohaemorrhagiae, canicola, 
grippotyphosa, and australis (Klaasen, van der Veen, Sutton and Molkenboer, 2014). 
According to Hartskeerl et al., (2011), the bacteria that causes leptospirosis is unique in 
that it can survive outside of the host, lengthening its life cycle. The bacteria is 
commonly transferred by wildlife, through excretion in urine and transferred to other 
species through mucous membranes (Brown & Prescott, 2008). However, leptospirosis 
can infect just about every mammal, with canines being the primary carrier for humans 
(Meredith, 2011). The disease can appear asymptomatically or produce an infection that 
impacts the kidneys, liver, and lungs, potentially becoming fatal (Brown & Prescott, 
2008). Household canines, usually the reservoir of the Leptospira interrogans, have 
become known as prominent carriers of the disease, and are able to transfer it to humans 
and other animals through urine (Andre-Fontaine, 2006); however, vaccination has been 
shown to prevent infection and renal shedding of the bacteria (Schreiber et al., 2005). 
 Although leptospirosis had been removed from the list of notifiable diseases by 
the Center for Disease Control and Prevention (CDC) in 1994, in June 2012 it was 
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reinstated by the Council of State and Territorial Epidemiologists as a Nationally 
Notifiable Condition (Guerra, 2013); furthermore, it was reinstated as a nationally 
notifiable disease in January 2013 (CDC, 2015). Thus, leptospirosis is emerging globally 
and is becoming recognized as a public health issue due to changes in climate, increased 
chances of natural disasters, and increased human-animal contact (Guerra, 2013). This 
thesis aims to provide knowledge regarding leptospirosis in humans and in canines, a 
common reservoir of leptospirosis that may pose a risk for humans in the transmission of 
leptospirosis. 
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Specific Aims 
 
The aims of this thesis include:  
1. Exploring the taxonomy and microbiology of Leptospira strains. 
2. Investigating the transmission of leptospirosis to both domestic animals and 
humans.  
3. Assessing the manifestation of disease in both domestic animals and humans.  
4. Evaluating the efficacy of testing and treatment in both domestic animals and 
humans. 
5. Validating the necessity of vaccination of animals in limiting the transmission of 
leptospirosis. 
6. Analyzing the global implications of leptospirosis.   
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Taxonomy of Leptospira 
 
 Leptospirosis is an infection caused by bacteria of the genus Leptospira, a 
member of the Leptospiraceae family (Levett, 2001). Leptospira is composed of 20 
species, 6 non-pathogenic (saprophytic), 5 intermediately pathogenic, and 9 pathogenic 
(Figure 1). Leptospira can be further divided into two species, L. biflexa, containing the 
saprophytic strains, and L. interrogans, containing the pathogenic strains (Levett, 2001). 
Interestingly, saprophytic strains live in soil and water sources, and yet, they can never 
cause leptospirosis (Adler, 2011). Within L. interrogans, there are more than 250 
pathogenic serovars, or strains, that differ based on antigenicity, which is characterized 
by the differences in the carbohydrate portion of the lipopolysaccharide on the bacterial 
membrane. Serovars can be associated with particular wild and domestic animals 
reservoirs (Table 1); furthermore, they can be divided into serogroups, which are 
important in vaccine development because immunity to leptospires is specific to 
serogroups (Table 2).  
 This thesis will focus on the L. interrogans as it is contains the common serovars 
found in canines, including canicola, autumnalis, grippotyphosa, and pomona and the 
common serovars in humans, including lai or copenhageni, with copenhageni being the 
most common cause of severe leptospirosis in humans (Adler et al., 2011). Furthermore, 
L. interrogans is a strain that is able to survive in the environment for long periods of 
time, providing a larger opportunity of transmission to both animals and people 
(Patarakul, Lo, & Adler, 2010). 
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Figure 1. The Pathogenic, Intermediately Pathogenic, and Nonpathogenic Strains of 
Leptospira. Figure taken from Meredith, 2011.  
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Table 1. Common Reservoir Animal Hosts and Their Corresponding Serovars. The 
table shows the serovar for the canine reservoir host in canicola. The table also shows the 
serovars for the reservoir host of rats are both icterohaemorrhagiae and copenhageni. 
Taken from Bharti et al., 2003. 
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Table 2. Serogroups of Leptospira Interrogans and Corresponding Serovars. Note the 
Icterohaemorrhagiae serogroup contains the following serovars: icterohaemorrhagiae, 
copenhageni, and lai. Taken from Bharti et al., 2003.   
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Microbiology of Leptospires 
 
 Leptospirosis is caused by leptospires, which are aerobic spirochetes, a bacterial 
family that includes the two genera, Leptospira and Leptonema. The genome of 
Leptospira spp, the pathogenic species that causes leptospirosis, contains two circular 
chromosomes, which are viable in many environments, such as free in the environment or 
in animal hosts, with optimal growth at 28 to 30° C; therefore, leptospires survive longer 
in warm, humid environments such as the tropics (Bharti et al., 2003; Levett, 2001). The 
highly motile leptospires are composed of tightly wound spirochetes, approximately 0.1 
µm by 6 to 0.1 µm by 20 µm, with ends that are hooked (Figure 2). With the narrow 
helical nature and the ability to move, the spirochetes are able to easily attach to tissue 
(Plank & Dean, 2000). The leptospires colonize the proximal tubules of the kidney of 
their animals host, allowing for an easy transmission through urinary excretion (Adler et 
al., 2011).  
Figure 2. Leptospira Interrogans Serovar Icterohamorrhagiae Scanning Electron 
Micrograph. The figure presents two leptospires on a membrane filter. Figure taken 
from Levett, 2001.   future classifications. However, the molecular classification isproblematic for the clinical microbiologist, because it is clearly
incompatible with the system of serogroups which has served
clinicians and epidemiologists well for many years. Until sim-
pler DNA-based identification methods are developed and
validated, it will be necessary for clinical laboratories to retain
the serological classification of pathogenic leptospires for the
foreseeable future. In addition, the retention of L. interrogans
and L. biflexa as specific names in the genomic classification
also allows nomenclatural confusion. In the following pages,
specific names refer to the genomospecies, including L. inter-
rogans sensu stricto and L. biflexa sensu stricto.
Biology of Leptospires
Leptospires are tightly coiled spirochetes, usually 0.1 !m by
6 to 0.1 by 20 !m, but occasional cultures may contain much
longer cells. The helical amplitude is approximately 0.1 to 0.15
!m, and the wavelength is approximately 0.5 !m (213). The
cells have pointed ends, either or both of which are usually
bent into a distinctive hook (Fig. 1). Two axial filaments
(periplasmic flagella) with polar insertions are located in the
periplasmic space (550). The structure of the flagellar proteins
is complex (583). Leptospires exhibit two distinct forms of
movement, translational and nontranslational (60). Morpho-
logically all leptospires are indistinguishable, but the morphol-
ogy of individual isolates varies with subculture in vitro and can
be restored by passage in hamsters (186). Leptospires have a
typical double membrane structure in common with other spi-
rochetes, in which the cytoplasmic membrane and peptidogly-
can cell wall are closely associated and are overlain by an outer
membrane (254). Leptospiral lipopolysaccharide has a compo-
sition similar to that of other gram-negative bacteria (603), but
has lower endotoxic activity (519). Leptospires may be stained
using carbol fuchsin counterstain (211).
Leptospires are obligate aerobes with an optimum growth
temperature of 28 to 30°C. They produce both catalase and
oxidase (530). They grow in simple media enriched with vita-
mins (vitamins B2 and B12 are growth factors), long-chain fatty
acids, and ammonium salts (309). Long-chain fatty acids are
utilized as the sole carbon source and are metabolized by
"-oxidation (530).
Culture Methods
Growth of leptospires in media containing either serum or
albumin plus polysorbate and in protein-free synthetic media
has been described (587). Several liquid media containing rab-
bit serum were described by Fletcher, Korthoff, Noguchi, and
Stuart (587); recipes for these earlier media are found in sev-
eral monographs (24, 213, 548, 634). The most widely used
medium in current practice is based on the oleic acid-albumin
medium EMJH (184, 310). This medium is available commer-
cially from several manufacturers and contains Tween 80 and
bovine serum albumin. Some strains are more fastidious and
require the addition of either pyruvate (312) or rabbit serum
(196) for initial isolation. Growth of contaminants from clinical
specimens can be inhibited by the addition of 5-fluorouracil
(311). Other antibiotics have been added to media for culture
of veterinary specimens, in which contamination is more likely
to occur (8, 413). Protein-free media have been developed for
use in vaccine production (64, 504, 518, 541).
Growth of leptospires is often slow on primary isolation, and
cultures are retained for up to 13 weeks before being dis-
carded, but pure subcultures in liquid media usually grow
within 10 to 14 days. Agar may be added at low concentrations
(0.1 to 0.2%). In semisolid media, growth reaches a maximum
density in a discrete zone beneath the surface of the medium,
which becomes increasingly turbid as incubation proceeds.
This growth is related to the optimum oxygen tension (213)
and is known as a Dinger’s ring or disk (164). Leptospiral
cultures may be maintained by repeated subculture (608) or
preferably by storage in semisolid agar containing hemoglobin
(213). Long-term storage by lyophilization (31) or at #70°C
(20, 432) is also used.
Growth on media solidified with agar has been reported
(494, 587). Colonial morphology is dependent on agar concen-
tration and serovar (582). Media can also be solidified using
gellan gum (496). Solid media have been used for isolation of
leptospires (572), to separate mixed cultures of leptospires,
and for detection of hemolysin production (539).
Molecular Biology
Leptospires are phylogenetically related to other spirochetes
(446). The leptospiral genome is approximately 5,000 kb in size
(52, 669), although smaller estimates have been reported (558,
649). The genome is comprised of two sections, a 4,400-kb
chromosome and a smaller 350-kb chromosome (669). Other
plasmids have not been reported (125, 292). Physical maps
have been constructed from serovars pomona subtype ken-
newicki (669) and icterohaemorrhagiae (74, 552). Leptospires
contain two sets of 16S and 23S rRNA genes but only one 5S
rRNA gene (230), and the rRNA genes are widely spaced (51,
231).
The study of leptospiral genetics has been slowed by the lack
FIG. 1. Scanning electron micrograph of L. interrogans serovar ic-
terohaemorrhagiae strain RGA bound to a 0.2-!m membrane filter.
Reproduced from eferenc 625a with per ission from the publisher.
VOL. 14, 2001 LEPTOSPIROSIS 299
 on April 2, 2015 by Boston Univ
http://cmr.asm.org/
Downloaded from 
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 The spirochete is a Gram-negative bacterium, composed of a plasma membrane, 
containing lipoproteins, outer membrane proteins (OMPs), and porins, which allow 
movement of particles from the periplasmic space and a cell wall (Figure 3). Within the 
periplasmic space, the spirochete contains two periplasmic flagella (PF) that allow for the 
unique motility of the bacterium, providing the ability to traverse through thick 
connective tissue (Li, Motaleb, Sal, Goldstein, & Charon, 2000). Leptospire motion is 
variable, with movement around a central axis or movement in the direction of the 
straight section (Bharti et al., 2003).  
 The major component of the outer membrane is lipopolysaccharides (LPS), which 
maintain the structure and allow survival of the bacteria in multiple environments; 
however, this structural stability can be interrupted through chelation of divalent cations 
between the lipopolysaccharides (Haake & Matsunaga, 2010). The lipopolysaccharides 
contain antigens, which are immunogenic and specific to certain serovars (Levett, 2001). 
The antigens obtained from LPS have been found to provide immunity against specific 
serovars in mice, rabbits, and guinea pigs (Levett, 2001).   
 Many other lipoproteins, LipL32, Loa22, Lig A, and Lig B, are also present on 
the outer membrane and have the ability to interact with host proteins, playing a role in 
the survival of leptospires in the mammalian host (Haake & Matsuaga, 2010). LipL32, is 
the predominant lipoprotein of the cell membrane and has the ability to interact with the 
proteins of the host basement membrane; however, it does not have a necessary role in 
pathogenesis. The second major lipoprotein, Loa22, is unique in that it is able to traverse 
into the periplasmic space and is required for virulence (Haake & Matsunaga, 2010). A 
 11 
third lipoprotein, the leptospiral immunoglobulin-like repeat proteins or Lig proteins (A 
or B) protrude from the outer membrane and are able to contact the extracellular matrix 
of the host, allowing for adhesion. The Lig A and Lig B proteins were found to be 
expressed during infection of a mammalian host, with increased production occurring at 
an osmolarity closer to that of a mammalian host, approximately 300 mOsm (Haake & 
Matsunaga, 2010). 
 The major transmembrane porin of the leptospire is the OMPL1, is a genus-
specific antigen only observed in the pathogenic leptospire, with an increased presence 
during infection (Dezhbord, Esmaelizad, Khaki, Fotohi, & Moghaddam, 2014). 
According to the study by Maneewatch et al. (2007), a vaccine developed using clones 
DNA of the OMPL1 provided reduced mortality in vaccinated hamsters, thus proving the 
OMPL1 porin may be an important target in vaccine development.  
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Figure 3. Diagram of the Leptospiral membrane.  The Gram-negative bacterium 
membrane is made up of many lipopolysaccharides (LPS), outer membrane lipoproteins 
(OMPs), and transmembrane species. The inner membrane (IM) comes into close contact 
with peptidoglycan (PG) cell wall in the periplasm. The major OMP is LipL32, followed 
by Loa22. The Loa22 is depicted with its transmembrane characteristic with its unique 
ability to interact with the periplasmic space. This depiction omits typical Gram-negative 
bacterium characteristics, such as the Ton-B dependent receptor. This figure was taken 
from Fraga, Barbosa, & Isaac, 2011.  
  
shape, spirochetes emerged early in eubacterial evolution.
The Leptospira genus includes pathogenic and saprophytic
species, being classified into more than 200 serovars con-
sidering the structural heterogeneity of the carbohydrate
moiety of lipopolysaccharide (LPS) [4]. Besides this anti-
genic classification, taxonomy based on genetic similari-
ties is currently being employed [5].
Leptospires are thin and highly motile spirochetes
with hooked ends (Fig. 1). They have two periplasmic
flagella subterminally attached that confer both transla-
tional and non-translational forms of movement [4]. Like
other spirochetes, leptospires have a distinctive double-
membrane architecture, sharing characteristics of both
Gram-positive and Gram-negative bacteria. The lepto-
spiral cytoplasmatic membrane is closely associated with
a peptidoglycan cell wall, which is overlaid by an outer
membrane [6] (Fig. 2). Phospholipids, outer membrane
proteins (OMPs) and LPS are the main components of
the outer membrane [7]. Leptospiral LPS has a lower
endotoxic potential compared with Gram-negative LPS,
possibly related to the unusual features of its Lipid A
component [4, 8]. To date, according to mutagenesis
Figure 1 Transmission electron micrographs of Leptospira interrogans serovar Pomona. (A) Leptospires are thin, helically coiled bacteria, classed in the
order Spirochaetales [4]. These highly motile spirochetes are normally about 0.1–0.2 lm wide and 6-20 lm long. They have two periplasmic flagella
and characteristic hooked ends. Original magnification, ·12,000. (B) Immunoelectron microscopic localization of LipL32, an abundant, surface-
exposed, outer membrane protein of pathogenic Leptospira. Original magnification, ·20,000. Courtesy of Dr Aurora Cianciarullo and Dr Ene´as de
Carvalho, Instituto Butantan, Sa˜o Paulo, Brazil.
Figure 2 Schematic depiction of leptospiral membrane architecture. The inner membrane (IM) is closely associated with the peptidoglycan (PG) cell
wall, which is overlaid by the outer membrane (OM) [6]. Surface-exposed lipoproteins (LipL32, LigA, LigB and L a22), the transmembrane outer
membrane protein porin L1 (OmpL1), and lipopolysaccharide are among the main components of the outer membrane. For simplicity, TonB-depen-
dent receptor systems, leptospiral lipoprotein export apparatus and endoflagella were omitted.
T. R. Fraga et al. Leptospiral Immunity 409
..................................................................................................................................................................
! 2011 The Authors
Scandinavian Journal of Immunology ! 2011 Blackwell Publishing Ltd. Scandinavian Journal of Immunology 73, 408–419
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Factors Influencing the Virulence of Leptospira 
 
 Leptospira virulence mechanisms are interesting, especially because the known 
proteins found in the bacterial membrane alone are non-virulent. Through sequencing the 
genome of particular strains of Leptospira, the patterns of gene regulation can be 
determined and in turn, the behavior of the proteins that make up the bacteria under 
specific conditions. According to Adler et al. (2011), a comparison of genomes of L. 
interrogans and L. borgpetersenii, two pathogenic strains, with the saprophytic strain, L. 
biflexa, shows that these strains has 2050 genes in common, also called the core genome 
of Leptospira.  
 When bacteria are found in a stressful environment, they typically express 
different proteins to improve their chance of survival (Matsunaga et al., 2007). Through 
comparing the pathogenic strains and saprophytic strain of the genome of Leptospira, 6 
genes were found to be absent in the saprophytic L. biflexa strain, and thus possibly cause 
virulence or allow survival in host environments of pathogenic strains (Adler et. al., 
2011). Furthermore, as will be described below, virulence of Leptospira can be affected 
by varying temperature, the presence of serum, the presence of iron, or the osmolarity.  
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 Temperature  
 A study by Lo et al. (2006), examined the effect of varying temperatures on the 
transcription of proteins in the L. interrogans serovar, lai. The goal of this study was to 
evaluate the regulation of gene expression, providing information on what genes are 
involved in the maintenance and growth of the bacteria inside the host. The strain was 
grown in cultures at environmental temperatures of 20o C, that of ambient temperature 
and 30 C, as would occur in laboratory condition, and also physiological temperatures, 
common to a normal and pyretic mammalian host, of 37o C and 39o C, respectively. The 
researchers examined the change in regulation of the genes through comparing 
expression differences between two of the temperatures, with a 1.5 fold change 
representing a difference in expression.  
 The study found that with a greater change in temperature, more were expressed 
differently. For example, in comparing 20o C to 39o C, 391 genes were differentially 
expressed, while in comparing 37o C to 39o C, only 25 genes were differentially 
expressed. Furthermore, most genes were expressed differently when comparing the 
physiological temperatures with the environmental temperatures, representing the 
necessary changes that must occur to colonize and maintain the bacteria in the host.  
 Not surprisingly, many of the genes were that were found to be differentially 
expressed were involved in chemotaxis, cell signaling, and motility, valuable abilities for 
such a highly motile and invasive pathogen like L. interrogans.  For instance, crp, the 
cAMP-binding transcriptional regulatory protein, is up-regulated with an increase in 
temperature from 30o C to 37o C.  
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A gene involved in the flagellar motility, flgL, was found to be up-regulated in 
response to the increased temperature of the host, allowing for invasion of the bacterium 
and infection in the host. Another gene, encoding for the enzyme katE, a catalase that 
prevents the oxidative degradation of the bacterium by hydrogen peroxide, was also up-
regulated at physiological temperatures, a possible mechanism of maintaining survival in 
the host environment. Lig B, a lipoprotein of the outer membrane that is found on 
virulent strains, such as copenhageni, was found to be up-regulated in the physiological 
temperature of 37o C compared to 30o C.  
Osmolarity 
 According to Matsunaga et al. (2007), when the bacteria of L. interrogans invade 
a host species, the bacteria move from an environment of low osmolarity to one of high 
osmolarity. It has also been shown that the genes regulating the expression of lipoprotein 
LigA and LigB are up-regulated with an increase in osmolarity, a sign that higher 
osmolarity may enhance virulence. The study involved examining the response of L. 
interrogans serovar copenhageni to a medium including sodium chloride, providing an 
environment with physiological osmolarity (~300 mOsM) compared an environmental 
osmolarity (~66 mOsM). After exposure to a medium of 300 mOsM for 20 hours at 30 C, 
124 genes were identified as salt-induced, while 94 genes were identified as salt-
repressed, representing a total of 6% of the genome being differentially expressed with 
higher osmolarity (Matsunaga et al. 2007).  
 Since OMPs are on the bacterial membrane and are exposed to the environment, 
they appear to be important when it comes to the survival of bacteria in changing 
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environments. According to this study, lipoproteins were a major source of differential 
gene expression when L. interrogans was introduced to the medium with higher 
osmolarity. One important gene affected by osmolarity is the ligB adhesin, with its 
expression increased at physiological osmolarity (Matsunaga et al. 2007).   
Serum 
 According to Patarakul et al. (2010), serum is important in the early stages of 
infection because the leptospires must survive and travel through the bloodstream in 
order to get to and harm target organs. The study performed by Patarukul et al. (2010), 
involved exposing L. interrogans serovar copenhageni to 50% guinea pig serum and 
comparing the genome of that in a typical medium. The findings showed differential gene 
expression for 168 genes (4.5% of the genome), with 55 up-regulated and 113 down-
regulated. One gene, that has been common to the other virulent factors as well, was 
LigB, the lipoprotein that allows for attachment to the host, was also up-regulated by 
contact with serum.  The genes that were found to be differentially expressed were 
mostly involved in metabolism.  One important gene, hemO, encodes heme oxygenase, 
and was up-regulated by the presence of serum. Heme oxygenase cleaves the tetrapyrrole 
ring of iron in aerobic settings and releases Fe2+ from heme. HemO was also found to be 
up-regulated if grown in a medium with hemoglobin.  
 
Iron 
 Iron is important in many biological reactions because of its ability to accept and 
donate electrons; in addition, iron contributes to the pathogensis of bacteria by allowing 
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the bacteria to survive in the host (Sritharan, Asuthkar, & Sridhar, 2006). According to 
Lo et al. (2010), iron is important in the virulence of many bacteria. In the host, iron is 
bound to protein carriers and thus has low availability; however, in order to overcome the 
low iron, bacteria have developed adaptations that allow iron attainment. For instance, L. 
interrogans contains four homologs of Fur, the ferric uptake regulator, and controls the 
genes allowing the bacteria to attain iron. Typically, when iron levels are high, Fur binds 
to ferrous iron, blocking transcription of genes. On the other hand, with iron limitation, 
the Fur-iron complex dissociates, preventing the binding of Fur and enhancing expression 
of target genes. Due to the need of iron, leptospires that are pathogenic have adapted to 
both generate heme and obtain iron in vivo by utilizing heme oxygenase on hemoglobin. 
The genes, hemE and hemL, are involved in regulating the synthesis of heme. 
Intracellular heme can also be accessed by hemolysins secreted by the pathogenic 
bacteria, which cause chemotaxis of hemoglobin (Sritharan et al., 2006).  
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Transmission of Leptospirosis 
 
 According to the paper written by Mackenstedt, Jenkins, and Romig (2015), 
increased urbanization has caused environmental changes that impact the transmission of 
disease by wildlife. Wild animals, including rats, swine, cattle, and raccoons, but also 
domestic animals, such as dogs and cats, can be reservoirs for one or more of the possible 
leptospirosis serotypes, eliminating the leptospires in urine for months or years (Brown & 
Prescott, 2008). More recent research has also found that ticks may also be possible 
vectors of leptospirosis (Wasinski & Dutkiewicz, 2013).  
The small mammals that transmit the leptospires through urine are referred to as 
maintenance hosts, commonly transferring the disease directly to farm animals and dogs, 
and indirectly to humans (Levett, 2001). Maintenance hosts usually are asymptomatic 
even with endemic infections starting early in life; in addition, they colonize leptospires 
in the proximal renal tubule (Figure 4), excreting them into the urine.   
 
 
 
 
 
 
 
 
 
 
 
Figure 4. Histology of Proximal Tubule Cells of a Hamster Infected with 
Leptospirosis. The proximal tubule cells have been stained with an antiserum that 
highlights the location of leptospires. The leptospires are seen lining the lumen of 
proximal tubule cells of the kidney (black arrow). Figure taken from Adler & de la Peña 
Moctezuma, 2010.  
Hardjo in cattle and Australis and Pomona in pigs (Andre´-
Fontaine, 2006; Bernard, 1993; Ellis et al., 1986; Grooms,
2006). However, other serovars can be involved in more
serious disease. Four syndromes have been identified in
dogs: icteric, hemorrhagic, uremic (Stuttgart disease) and
reproductive (abortion and premature or weak pups).
Typical leptospirosis in dogs may present with fever,
jaundice, vomiting, diarrhea, intravascular disseminated
coagulation, uremia caused by renal failure, hemorrhages
and death (Bolin, 1996). In cattle and pigs, signs of
leptospirosis include reproductive failure, abortion, still-
births, fetal mummification, weak piglets or calves and
agalactia. A chronic manifestation of leptospirosis is
commonly seen in horses as recurrent uveitis (Rohrbach
et al., 2005), but is not unique to this species and may also
be seen occasionally in humans. Animals recovering from
leptospirosis may become asymptomatic carriers harbor-
ing virulent leptospires in the renal tubules for extended
periods and shedding infectious leptospires into the
environment (Levett, 2001). Susceptible animals acquire
the infection by direct or indirect contact with urine or
tissues of infected animals. Other species such as mice
(Mus musculus and other Mus species) and rats (mainly
Rattus norvegicus and R. rattus) serve as reservoirs for their
host-related serovars (mice for Ballum, Icterohaemorrha-
giae and rats for Copenhageni) (Bharti et al., 2003). They
usually do not show signs, but harbor leptospires in their
kidneys, becoming an important source of infection for
humans or other animals.
3. Leptospirosis the zoonosis
It is beyond the scope of this review to cover the details
of the varied clinical aspects of infection with Leptospira in
humans and the reader is referred to the following detailed
information on specific clinical presentations in leptos-
pirosis: (Bharti et al., 2003; Faine et al., 1999; Levett, 2001).
Leptospirosis in humans is always acquired from an animal
source; human-to-human transmission is for practical
purposes non-existent and the disease is regarded globally
as a zoonosis. Pathogenic leptospires live in the proximal
renal tubules of the kidneys of carriers (Fig. 2), although
other tissues and organs may also serve as a source of
infection. From the kidneys, leptospires are excreted in
urine and may then contaminate soil, surface water,
streams and rivers. Infections of animals or humans occur
from direct contact with urine or indirectly from con-
taminated water. The carriers may be wild or domestic
animals, especially rodents and small marsupials, cattle,
pigs and dogs (Fig. 3). Almost every mammal (including
aquatic mammals) and marsupial worldwide has been
shown to be a carrier of leptospires. Humans almost never
become chronic carriers, but suffer acute infections,
sometimes with longer term sequelae.
Leptospirosis in humans can vary in severity according
to the infecting serovar of Leptospira, and the age, health
and immunological competence of the patient. It ranges
from amild, influenza-like illness to a severe infectionwith
renal and hepatic failure, pulmonary distress, and death
(the classical Weil’s disease). There is a worldwide
occupational association, especially in developed coun-
tries, with agriculture and animal productio (cropping,
dairy farming, pig production, abattoirs) and a universal
risk from rodent-carrier mediated infection, especially
prevalent in tropical countries, where many serovars may
be present in a locality. There are characteristic associa-
tions of particular serovars with certain species of animals
as carriers, but the association is not absolute and the
molecular basis for this so-called maintenance host
‘‘specificity’’ is unknown.
The renal carrier state is thus a key component which is
central to the persistence and epidemiology of leptospiro-
sis. Leptospires colonise the surfaces of renal proximal
tubular epithelial cells. The molecular basis for this
bacterial-cell association is unknown. Specific adhesion
factors of leptospires for host components have been
described, but their role in disease has not been elucidated.
For example, the fibronectin-binding protein LigB is not
necessary for virulence, while the major surface protein
LipL32 binds host ECM, but is not required for either acute
infection or kidney colonisation. Excretion in urine may be
intermittent or continuous and the urinary concentration
of bacteria may be as high as 108/ml. Leptospires do not
survive well in acid urine, but remain viable in alkaline
urine. Consequently, herbivores and animals whose diet
produces alkaline urine are relatively more important as
shedders than are producers of acid urine.
Leptospirosis commences suddenly with headache,
fever (typically to 102 8F, 39 8C) malaise, myalgia, con-
junctival suffusion and sometimes a transient rash.
Thereafter the illness may be mild and self-limiting or
severe and fatal. The mild type may be serious and
incapacitating, but seldom leads to kidney or liver failure,
hemorrhages or death.
This description is applicable worldwide to illness
characteristically seen commonly in infection with serovar
Hardjo, but also with others. On the other hand, infection
with some of these usually milder serovars can occasion-
ally lead to severe leptospirosis which may be life
threatening. For example, human infection with Pomona
may lead to renal failure, while severe cholecystitis has
been reported for Hardjo infections. The initial symptoms
Fig. 2. Immunohistopathology of infected hamster kidney. Leptospires
stainedwith specific antiserum (arrow) are seen lining the proximal renal
tubules.
B. Adler, A. de la Pen˜a Moctezuma / Veterinary Microbiology 140 (2010) 287–296 289
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 Domestic animals become infected through contact through mucous membranes 
with leptospires of wildlife urine in contaminated water or soil (Brown & Prescott, 2008). 
According to Levett (2001), as early as 1917, rats were found to be the source of human 
leptospirosis through the indirect transmittance of the L. interrogans serovar 
icterohaemorrhagiae in water or soil. This discovery led to the recognition that canines 
could be a possible vector for the disease as well. Humans become infected with 
leptospirosis through contact with affected urine on mucosal membranes or abrasions on 
skin by encountering contaminated water sources, soil, or even direct contact with an 
affected animal (Figure 5). Although leptospires have also been found in the excreted 
urine of humans, direct transmission between humans has rarely been documented 
(Levett, 2001).   
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Figure 5: Transmission of Leptospirosis From Wildlife to Humans. Raccoons and 
wildlife are typically asymptomatic carriers that spread the disease through their urine 
into soil, mud, and water sources. This provides the means of transmission to domestic 
animals and humans both directly from their household pets and indirectly through soil 
and water sources.  Figure taken from Brown & Prescott, 2008. 
 
 
Invasion and Phagocytosis of Leptospira 
 According to Fraga et al. (2011), pathogenic leptospires are able to bind to the 
areas of the extracellular matrix, such as collagen I and IV, fibrinogen, elastin, and 
laminin more efficiently than saprophytic organisms. L. interrogans attach to epithelial 
Practice
In North America, there is a low in-cidence of leptospirosis that occursas a result of direct transmission of
the bacterium from dogs to its owners
and their families. It is not mandatory
for leptospirosis to be reported to
health authorities in Canada, thus it is
likely underreported. It is important to
take the precautions outlined below to
reduce the risk of exposure, especially
when young children and elderly 
people are involved.
Leptospirosis, also known as fall
fever or mud fever, affects both animals
and humans (Figure 1). The disease is
caused by the spirochete Leptospira,
which has about 200 serotypes.1–3 The
severity of illness may depend on the
serotype, and it can range from an
asymptomatic infection to a fatal ill-
ness involving the kidneys, liver and
other vital organs (Box 1). However,
there is no serotype-specific presenta-
tions of infection, and each serotype
may cause mild or severe disease de-
pending on the host. The virulence fac-
tors of leptospires are poorly under-
stood. Patient factors such as old age
and multiple underlying medical prob-
lems are often associated with more
severe clinical illness and increased
mortality.5 The infectious dose may
also have an influence on the course of
leptospirosis.
This disease occurs worldwide, and
the highest prevalence is in tropical cli-
mates and in warm and wet environ-
ments with poor sanitary conditions.
The advent of animal vaccines against
specific serotypes has reduced the risk
of transmission to humans.6 Before the
serotype Leptospira canicola was con-
trolled in dogs by immunization, for
example, cases of very serious disease
involving disseminated intravascular
coagulation were reported in children
in the United States.6 In Canada, cases
involving humans are uncommon.
However, the incidence of infections in
domestic dogs has risen markedly in
recent years in the United States and
Canada,7 thus veterinarians and physi-
cians should be alert to the possibility
of transmission. 
A variety of wild and domestic ani-
mals can act as reservoir hosts for 1 or
more serotypes and can shed the or-
ganism in their urine for months or
years after being infected (Figure 1).
This includes dogs, rats, swine, cattle
and, in North America, raccoons.2 Pets
may come into contact with leptospires
by contact with wildlife urine or farm
animal reservoirs through activities
such as swimming, drinking or walk-
ing through contaminated water, soil
or mud. Humans become infected
through contact of mucosal surfaces or
abraded skin with contaminated soil or
water or with animal urine or tissues.
For example, participating in recre-
ational activities in contaminated water
increases the risk of infection (Box 2).1
Disease activity tends to be higher dur-
ing the autumnal climate that occurs in
most of the populated areas of Canada.
Leptospirosis in the family dog: a public health perspective 
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cells, particularly in the renal proximal tubule, where they continue to colonize. 
Compared to the saprophytic bacterium, pathogenic strains of L. interrogans have been 
shown to be very invasive, with the ability to translocate through Mardin-Darby Canine 
Kidney (MDCK) cells faster and also have a shorter lifespan within cells, allowing for 
evasion from an immediate immune response.  
  Leptospires that are marked by an antibody, in a process called opsinization, can 
typically be engulfed and destroyed by macrophages (Levett, 2001). Polymorphonuclear 
neutrophils (PMNs) are thought to play a major role in removing both saprophytic and 
pathogenic leptospires (Fraga et al, 2011). The mechanism utilized by PMNs involves 
hydrogen peroxide (H2O2) and the primary granules inside PMNs; however, pathogenic 
strains can be more resistant to degradation than non-pathogenic counterparts due to 
catalase activity by the enzyme katE.  
 In an experiment by Eshghi et al. (2012), the effectiveness of katE pertaining to 
the virulence of the pathogenic strain L. interrogans was examined. When an immune 
response is generated against Leptospira, a reactive oxygen species (ROS) is released 
upon Kupffer cells being exposed to the bacteria. The ROS is produced from free radicals 
of oxygen by neutrophils and macrophages. The ROS can then go on to produce another 
ROS, hydrogen peroxide, which is involved in killing bacteria. A catalase, such as katE, 
is important in the survival of pathogenic strains of Leptospira because it provides 
resistance to the phagocytic breakdown of bacteria. L. interrogans was found to have a 
50-fold increase in survival when under oxidative stress compared to that of L. biflexa 
because of its ability to break down H2O2. To examine the effect of katE on L. 
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interrogans, the katE enzyme was genetically inactivated through an insertion of DNA. 
The experiment involved injecting hamsters with a wild-type strains of katE from L. 
interrogans and comparing the results to that of hamsters injected with mutant katE. 
Hamsters injected with the wild-type strains of katE showed signs of infection, while 
those with the mutant form of the enzyme, which caused loss of katE expression, did not 
show symptoms. Because virulence is associated with the ability to survive in the host, 
katE has thus been shown to be an important component involved in increased virulence 
of the pathogenic strains of Leptospira (Eshghi et al. 2012).   
 
 
Immune Evasion by Pathogenic Strains of Leptospira 
 
 Typically, monoclonal or polyclonal antibodies against LPS antigens protect 
against leptospirosis. According to Fraga et al. (2011), serum has the ability to kill strains 
of Leptospira, thus, the ability of certain strains to survive within serum represents their 
virulence. During the first hours of infection, the innate immune system, consisting of 
both cell-mediated immunity, characterized by an increase in the αβ and γδ T-
lymphocytes in the peripheral blood and humoral-mediated immunity, responds through 
the alternative complement pathway. Overall, the alternative complement pathway is able 
to destroy the saprophytic strain L. biflexa; however, virulent, pathogenic strains are able 
to escape this system. Pathogenic strains are only destroyed by macrophages if proper 
antibodies are present; furthermore, these strains can actually survive inside 
macrophages, inducing apoptosis to mediate their escape (Adler, 2014).   
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 Other examples of immune evasion are the alternative complement pathway and 
the classical and lectin complement pathway, occurring with the serovar of L. 
interrogans, copenhageni, which causes severe cases of leptospirosis in humans, are 
described in the following sections. These pathways both incorporate the presence of 
regulatory proteins, either Factor H (FH) or C4b Binding Protein (C4BP) on the bacterial 
membrane. Through the presence of these proteins, opsinization is prevented, allowing 
for the evasion of the complement pathways and survival of pathogenic Leptospira.  
Alternative Complement Pathway  
 To activate the alternative complement system, IgG antibodies can either act as 
opsonins, binding to the Leptospira antigens, marking them for phagocytosis by 
macrophages and neutrophils, or they can cause agglutination of the leptospires. Another 
opsonin, pictured in Figure 6, C3b, produced after the complement system has been 
activated, is helpful in impeding the attachment of Leptospira to leukocytes.  
 The alternative complement pathway is inhibited with pathogenic strains through 
the three specific actions of Factor H (FH), a plasma protein. Factor H interrupts the 
binding of factor B to the opsonin C3b, allowing for a more rapid decay of the C3-
convertase, C3bBb. FH also acts as a cofactor for Factor 1, allowing the cleavage of C3b 
(Fraga et al., 2011). A major difference between the saprophytic strains and the 
pathogenic strains is the ability for the pathogenic strains to maintain all of these soluble 
proteins on their surface. For instance, the alternative complement pathway is effective in 
killing the saprophytic strains because the bacteria do not bind the regulatory protein, FH. 
This allows the C3 convertase to remain functional, cleaving C3 to C3b and C3a. The 
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C3a component is involved in an inflammation response, while C3b then acts as an 
opsonin.  
 
 
 
Figure 6. Alternative Complement Pathway for Saprophytic and Pathogenic 
Leptospira. On the left, the saprophytic Leptospira activates the alternative complement 
pathway because it fails to interact with the host regulatory protein, Factor H (FH). The 
C3b and C3a units formed upon the conversion of C3 are important in opsinization and 
inflammation, respectively. On the right, the pathogenic Leptospira inactivates the 
alternative complement pathway by interacting with FH, preventing the binding of C3b 
and Factor B, decreasing the C3 convertase activity. The two proteins, LenA and LenB, 
are ligands for human FH.  Len proteins are able to bind to extracellular matrices at the 
laminin. Figure amended from Fraga et al., 2011.   
of the O antigen compared with the LPS of leptospires
isolated from guinea pig liver with acute infection [88].
This increased content of LPS O antigen in chronically
infected kidneys could constitute an immune evasion
strategy. Indeed, the O antigen expression was associated
with complement resistance in Francisella tularensis, a fac-
ultative intracellular Gram-negative pathogen [89].
Therefore, the role of the LPS O antigen in the lepto-
spiral immune evasion should be evaluated.
Besides increased LPS O antigen content, proteomic
analysis revealed a reduced expression of antigenic pro-
teins in leptospires from rat kidneys in contrast to
in vitro cultured bacteria [90]. This antigenic reduction
could also reflect a means of escaping from host immune
responses.
Saprophytic and pathogenic leptospires are able to
form biofilms, helping them to survive in environmental
habitats and to colonize the hosts [91]. Indeed, biofilms
can constitute a barrier against the immune effector cells
and molecules, including antibodies and complement,
and represent one of the major mechanisms of Pseudomo-
nas aeruginosa persistence in chronic infections [92]. Inves-
tigations on biofilm formation by leptospires in renal
tubule cells from resistant and susceptible hosts could
certainly contribute to our understanding of immune
evasion strategies and disease pathology.
Figure 3 Complement evasion strategies in Leptospira. Saprophytic Leptospira are susceptible to complement-mediated killing because they do not bind
the host complement regulatory proteins Factor H (FH) [27] and C4b Binding Protein (C4BP) [28]. By contrast, pathogenic Leptospira evade comple-
ment attack by acquiring these soluble proteins of the alternative and classical pathways on their surfaces. Factor H, a 150-kDa plasma protein, inhib-
its the alternative pathway of complement by preventing binding of Factor B to C3b, accelerating decay of the C3-convertase C3bBb and acting as a
cofactor for the cleavage of C3b by Factor I. LenA and LenB are leptospiral ligands for human FH [82, 83]. C4BP is a 570-kDa plasma glycoprotein
that inhibits the classical pathway of complement by interfering with the assembly and decay of the C3-convertase C4bC2a and acts as a cofactor for
Factor I in the proteolytic inactivation of C4b. LcpA is a leptospiral outer membrane protein which interacts with human C4BP [85]. As a conse-
quence of the acquisition of those fluid-phase regulators on the surface of a given pathogen, complement activation is down-regulated preventing opso-
nization and the formation of the lytic membrane attack complex on its surface. In the schematic representation of FH and C4BP, each circle
represents one SCR domain. Open circles indicate the three SCR domains of the C4BP b-chain.
T. R. Fraga et al. Leptospiral Immunity 415
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Classical and Lectin Complement Pathways 
  
 
 Pathogenic Leptospira also have the ability to bind to another host complement 
regulatory protein, C4BP, which allows for the inactivation of the classical and lectin 
complement pathways (Figure 7). The C4BP is a plasma glycoprotein that is found in the 
host serum that interacts with the leptospiral OMP, LcpA. The C4BP is also able to 
prevent the assembly of the C3 convertase, C4bC2a, by interrupting the binding between 
the C4b and C2a units. Upon C4BP binding to the membrane proteins, the C2a unit 
disassociated from C4b, causing the decay of the C3 convertase. C4BP is also able to act 
as a cofactor with Factor 1, leading to the inactivation of C4b, also preventing C3 
convertase activity (Fraga et al., 2011).  
 The saprophytic Leptospira activates the classical and lectin complement 
pathways by avoiding the binding of C4BP. This allows the C3 convertase to remain 
functional, converting C3 to the opsonin, C3b, and the inflammation inducer, C3a.  
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Figure 7. Classical and Lectin Complement Pathway for Saprophytic and 
Pathogenic Leptospira.  On the left, the saprophytic Leptospira activates the classical 
and lectin complement pathways through avoiding the binding of the regulatory host 
protein, C4BP. This allows the retained activity of C3 convertase, C4bC2a, leading to the 
breakdown of C3 to C3b and C3a, the two necessary components that induce an immune 
response. On the right, the pathogenic Leptospira inactivates the classical and lectin 
complement pathways through the binding of C4BP to LcpA and the C3 convertase. 
Figure amended from Fraga et al., 2011. 
 
 
Time Scale of the Leptospirosis Infection 
 According to Levett (2001), upon the invasion of leptospires into mucous 
membranes, there is a 2 to 20 day incubation period. After the incubation period, 
leptospirosis presents as a biphasic infection, with an acute or septicemic phase, followed 
by an immune phase (Figure 8). The acute phase lasts approximately one week, with the 
of the O antigen compared with the LPS of leptospires
isolated from guinea pig liver with acute infection [88].
This increased content of LPS O antigen in chronically
infected kidneys could constitute an immune evasion
strategy. Indeed, the O antigen expression was associated
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ultative intracellular Gram-negative pathogen [89].
Therefore, the role of the LPS O antigen in the lepto-
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and represent one of the major mechanisms of Pseudomo-
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tigations on biofilm formation by leptospires in renal
tubule cells from resistant and susceptible hosts could
certainly contribute to our understanding of immune
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quence of the acquisition of those fluid-phase regulators on the surface of a given pathogen, complement activation is down-regulated preventing opso-
nization and the formation of the lytic membrane attack complex on its surface. In the schematic representation of FH and C4BP, each circle
represents one SCR domain. Open circles indicate the three SCR domains of the C4BP b-chain.
T. R. Fraga et al. Leptospiral Immunity 415
..................................................................................................................................................................
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major symptom being a fever. During this phase, leptospires begin to appear in the blood 
and cerebral spinal fluid, a valuable diagnostic to enhance early detection. Furthermore, 
during this first week of infection, the anti-Leptospira antibody titer rises from negative 
to low.  The following convalescent phase, also known as the immune phase, starts at the 
second week of infection and may be characterized by a slight fever; however, the most 
important characteristics found during this phase, are the presence of leptospires in urine 
and a rising level of antibodies produced that eventually plateaus at the end of the second 
week of infection. With early treatment, antibody titers can remain low during the 
immune phase (Levett, 2001)  
 There are two extremes of leptospirosis disease, the anicteric form and the icteric 
form. The major difference between these two forms of disease is jaundice, which 
appears only in icteric leptospirosis. The majority of cases are anicteric, a mild infection, 
usually asymptomatic; however, there are anicteric infections that do have mild 
symptoms of chills, abdominal pain and headache. Icteric leptospirosis is more severe 
and progresses rapidly; however, the symptoms of this severe form present later in the 
course of infection, leading to the increased mortality rate (Levett, 2001)   
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Figure 8. Timescale of Leptospirosis Infection. Leptospirosis is a biphasic infection, 
consisting of an acute stage followed by an immune stage. The acute stage occurs in the 
first week to ten days of infection, where the major symptom is a fever. During the acute 
phase, leptospires are found in both the blood and the cerebrospinal fluid and antibody 
titers rise from negative to low. In the immune phase, beginning at the second week, a 
slight fever may still be present. During this phase, leptospires are found in the urine and 
antibody titer levels reach their peak and eventually plateau. Figure taken from Levett, 
2001.  
  
ease represents only the most severe presentation. Formerly it
was considered that distinct clini al syndromes were associat d
with specific serogroups (596). However, this view was ques-
tioned by some authorities (18, 180, 220), and more intense
study over the past 30 years has refuted this hypothesis. An
explanation for many of the observed associations may be
found in the ecology of the maintenance animal hosts in a
geographic region. A region with a richly varied fauna will
support a greater variety of serogroups than will a region with
few animal hosts. In humans, severe leptospirosis is frequently
but not invariably caused by serovars of the icterohaemorrha-
giae serogroup. The specific serovars involved depend largely
on the geographic location and the ecology of local mainte-
nance hosts. Thus in Europe, serovars copenhageni and ictero-
haemorrhagiae, carried by rats, are usually responsible for
infectious, while in Southeast Asia, serovar lai is common.
The clinical presentation of leptospirosis is biphasic (Fig. 2),
with the acute or septicemic phase lasting about a week, fol-
lowed by the immune phase, characterized by antibody pro-
duction and excretion of leptospires in the urine (180, 325,
585). Most of the complications of leptospirosis are associated
with localization of leptospires within the tissues during the
immune phase and thus occur during the second week of the
illness.
Anicteric Leptospirosis
The great majority of infections caused by leptospires are
either subclinical or of very mild severity, and patients will
probably not seek medical attention. A smaller proportion of
infections, but the overwhelming majority of the recognized
cases, present with a febrile illness of sudden onset. Other
symptoms include chills, headache, myalgia, abdominal pain,
conjunctival suffusion, and less often a skin rash (Table 7). If
present, the rash is often transient, lasting less than 24 h. This
anicteric syndrome usually lasts for about a week, and its res-
olution coincides with the appearance of antibodies. The fever
may be biphasic and may recur after a remission of 3 to 4 days.
The headache is often severe, resembling that occurring in
dengue, with retro-orbital pain and photophobia. Myalgia af-
fecting the lower back, thighs, and calves is often intense (18,
325).
Aseptic meningitis may be found in !25% of all leptospiro-
sis cases and may account for a significant minority of all
causes of aseptic meningitis (57, 236, 503). Patients with asep-
FIG. 2. Biphasic nature of leptospirosis and relevant investigations at different stages of disease. Specimens 1 and 2 for serology are acute-phase
specimens, 3 is a convalescent-phase sample which may facilitate detection of a delayed immune response, and 4 and 5 are follow-up samples which
can provide epidemiologi al information, such as the presumptive infecting serogroup. (Adapted from reference 586a with permission of the
publisher.)
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Leptospirosis: A Veterinary Issue 
 
 Leptospirosis can infect almost any mammal, with reported cases in over 150 
mammalian species (Sykes et al., 2011). As well as being a very dangerous zoonotic 
disease, affecting humans and animals alike, it also has many other public health and 
economic implications. For instance, leptospirosis has caused economic loss in cattle and 
swine because of reproductive losses, due to a decrease in post-natal survival and 
possible abortion, that occur with infection (Adler et al., 2011). In addition, leptospirosis 
can be a very expensive disease to manage for pet owners because of the various 
treatment requirements (Hennebelle, Sykes, & Foley, 2014). 
 According to Sykes et al. (2011), both domestic canines and felines can be 
infected with leptospirosis; however, knowledge regarding feline transmission in the 
environment is not prominent. Canines are known as maintenance hosts for the serogroup 
canicola; however, this strain was only found causing disease in the 1950s. The major 
serovar, which has mainly been transmitted through rodent populations, has been isolated 
in canines and has also been found to be the cause of disease in humans around the world, 
is Icterohaemorrhagiae. Although the transmission in the United States from 
icterohaemorrhagiae is low, possibly due to improved control of rodent populations, 
leptospirosis continues to be known as an “emerging zoonosis”, with an increased 
incidence globally (Guerra, 2013). 
 Transmission from domestic dogs to humans has not been substantiated through 
molecular testing; however, there have been examples of contact through humans and 
their pets (Sykes et al., 2011). For example, in California, 10% of 61 leptospirosis cases 
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were caused by pet contact (Sykes et al., 2011). A very critical component in limiting the 
transmission of any zoonotic disease between pets and humans is client education, a task 
for a veterinarian (Stull, Carr, Chomel, Berghaus, & Hird, 2007). Communication 
between medical practitioners and veterinarians is also important in limiting zoonotic 
diseases. Medical practitioners may not be properly diagnosing zoonotic diseases that 
they see in patients because of the lack of diagnostic tools, but also because of the lack of 
communication in the medical field and the lack of awareness of the diseases (Damborg 
et al., 2015). 
 According to Meredith (2011), canines are currently thought to be the primary 
carrier for humans in the transmission of leptospirosis; however, zoonotic transmission 
from dogs is not well documented (Damborg et al., 2015). Nevertheless, insight into the 
serovars common in dogs will provide understanding into the possible serovar risks for 
humans, thus providing public health benefits (Davis et al., 2008). With leptospirosis 
cases slightly increasing in dogs, possibly due to the presence of new serovars not 
included in current vaccines, and increased prevalence of domestic animals in households 
around the United States, there is reason for concern of larger outbreaks; thus, the 
following section will examine the manifestations, testing, and treatment of leptospirosis 
specifically in canines.  
 
 
Client education regarding zoonotic disease  
 According to Damborg et al. (2015), pet owners and caretakers are often unaware 
of the various risks and sources of infection that their pets pose. A study, conducted by 
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Bingham, Budke, and Slater (2010) involved administering a questionnaire to 516 
individuals in Brazos County, Texas. The questionnaire focused mainly on pet owner’s 
responses to rabies and how they would handle a bite from a household pet or wild 
animal. This study found that only 59% of individuals participating in the survey were 
aware of the fatal risk of rabies. This study also found that while 94% of pet owners had 
seen a veterinarian in that year, only 50% remembered receiving information regarding 
zoonotic diseases.  
 Another study by Sandhu and Singh (2014) had similar results, again showing 
that clients lacked awareness regarding zoonotic diseases. This cross sectional study 
evaluated the awareness of 100 pet owners in Ithaca, New York regarding various 
zoonotic diseases, including leptospirosis. This study found that only 10% of participants 
were aware of leptospirosis and only 20 of the 100 participants had vaccinated their dogs 
against the disease.  
 Both of these studies indicate the lack of knowledge of pet owners regarding 
zoonotic diseases, representing that the lack of client education is major issue regarding 
the transmission of zoonotic disease. Furthermore, pet owners often look to veterinarians 
as the primary source of information regarding zoonotic diseases (Bingham, Budke, & 
Slater, 2010). Thus, veterinarians should provide pet caretakers and pet owners with 
information regarding zoonotic diseases due to the risks that they pose (Damborg et al., 
2015).  
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Risk Factors and Prevalence of Leptospirosis in Canines 
 The prevalence of leptospirosis varies geographically, with the largest number of 
cases occurring in tropical climates with high rainfall (Sykes et al., 2011). In the United 
States, dogs have been found to have high antibody titers for Leptospira especially in 
Hawaii, California, Oregon, Washington, Texas, Colorado, but also found in northeast 
and southeast states (Moore et al., 2006). In the study by Moore et al. (2006), the serum 
diagnostic microscopic agglutination test (MAT) titers, explained in more detail below, 
were examined for dogs between January 2002 and December 2004 from Antech 
Diagnostic Veterinary Laboratories for the serovars canicola, grippotyphosa, 
icterohaemorrhagiae, hardjo, pomona, autumnalis, and bratislava. Furthermore, as can 
be seen in Figure 9, the number of states affected by seropositivity of Leptospira 
increased between 2002 and 2004. According to the paper by André-Fontaine (2006), a 
study involving 2457 leptospirosis positive dogs over a 5 year span, showed that the 
icterohaemorrhagiae and canicola strains had the highest titers and were the most 
prevalent; however, there are four other strains that can also cause disease in dogs (Figure 
10). These other strains are transmitted to dogs through rodent or other wild mammal 
urine and also through contaminated lakes and puddles.  
 According to Sykes et al. (2011), leptospirosis is most prevalent during periods of 
high rainfall, with the peak of incidences in the United States occurring during the fall. 
Dogs are most at risk if they often visit areas that allow them to drink from rivers or lakes 
that could have been contaminated with affected urine from wild animals. Domestic 
animals in suburban areas can even be infected in their own backyards through the urine 
 33 
from wild animals. In developing countries, one of the largest sources of infection for 
dogs is exposure to sewage systems and rodent populations. While there is no limitation 
on age, breed, and sex when it comes to acquiring infections, it has been found that intact, 
male dogs that work outdoors or hunt are most at risk.   
 
 
 
Figure 9. Percentage of Seropositive Test Results by State. The results indicate an 
increased number of states in 2004 with >20% positive titers (meaning greater or equal to 
400) for serovars Autumnalis, Bratislava, Canicola, Grippotyphosa, Icterohaemorrhagiae, 
Pomona, or Hardjo. Figure taken from Moore et al., 2006.  
Dogs in suburban or r al e vironmen s have been
shown to be at increased risk of leptospirosis (15), presum-
ably because of greater likelihood of contact with wildlife
habitats. D gs may be s ntinels for human exposure to this
zoonotic organism. Veterinary practitioners and public
health officials need to be aware of the potential change in
the ecologic environment and circulating endemic strains
for this zoonotic organism.
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Figure 2. Canine leptospirosis microscopic agglutination test
results shown as the percentage positive and standard error, by
state and year from 2002 to 2004. A test was considered positive
if the titer for any serovar was >400 for Autumnalis, Bratislava,
Canicola, Grippotyphosa, Icterohaemorrhagiae, Pomona, or
Hardjo serovars.
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Figure 10. Percentage of Serogroups in Infected Dogs. IH: Icterohaemorrhagiae; CAN: 
Canicola; SJ: Sejroe; AUS: Australis; GRIP: Grippotyphosa; AUT: Autumnalis. The IH 
serogroup has the highest prevalence in infected dogs. This IH serogroup is the prominent 
strain shed by wild animals into the environment, and thus the higher percentage is 
realistic. Figure taken from André-Fontaine, 2006.  
 
 
Manifestations of Leptospirosis in Canines 
 
 According to Sykes et al. (2011), the author of the American College of 
Veterinary Internal Medicine (ACVIM) Small Animal Consensus Statement on 
leptospirosis, clinical manifestations of the disease can vary depending on the strain of 
Leptospira. While some dogs can lack any clinical signs of infection, making them a 
danger for transmission of disease to their families and other animals, others can develop 
a disease that is critical and potentially fatal.  
samples collected for the diagnosis of leptospirosis,
also from vaccinated dogs, support this fact. Since
many dogs are now vaccinated, agglutinating anti-
bodies against both vaccinal serogroups can be
expected (Ward et al., 2002). However, a discrepancy
of 20% has been found between the seroprevalence of
Icterohaemorrhagiae (0.76) and Canicola (0.56)
amongst more than 2400 positive canine serum
samples submited for serological diagnosis in France
(Fig. 1). The products of various vaccine manufac-
turers are of equal immunogenicity with respect to
both serogroups, and the same vaccinal seroprevalence
for both serogroups should therefore be expected. The
significantly higher Icterohaemorrhagiae seropreva-
lence, as seen in Fig. 2, can be most plausibly
explained as representing an anamnestic response in
previously vaccinated animals which are more
frequently in contact with field strains of Icterohae-
morrhagiae, as compared to Canicola strains. Like-
wise, in looking at the agglutination titres from dogs
suspected of clinical leptospirosis, purely vaccinal
titres should show a similar distribution in respect of
Icterohaemorrhagiae and Canicola. Very high titres
are generally only induced by field infection or by very
recent vaccination. Over the past 5 years we have
analysed 2457 positive canine serum samples by MAT
and have demonstrated that high titres occur more
frequently for Icterohaemorrhagiae than for Canicola
(Fig. 2).
All these results can be explained by the higher
natural infection pressure from Icterohaemorrhagiae
strains shed into the environment by wild animals
such as rodents (Michel et al., 2001). If the infection
pressure from Canicola is decreasing, this can be
explained by the fact that dogs are the natural reservoir
of Canicola and that widespread routine vaccination
has reduced the shedding of such strains from
vaccinated animals.
Serological responses to other serogroups of
leptospires are not uncommon (Fig. 1) and cannot
be explained by vaccination alone, except in the case
of lowMAT titres (<320), which may represent cross-
agglutination between different serogroups. But titres
of 320 or more for the serogroups Australis, Sejroe¨,
Grippotyphosa or Autumnalis cannot simply be the
result of previous vaccination (Fig. 2). High titres are
usually observed following acute disease with
significant bacteraemia or as a consequence of active
chronic infection. Thus, serogroups Australis and
Sejroe¨ appear to be responsible for more cases of
subacute and active chronic disease than Grippoty-
phosa and Autumnalis. The lower prevalence of high
titres for both would suggest that either the disease
was so acute that the animals had no time to develop
an immune response or that the strains are less
pathogenic.
How can dogs be infected by so many different
serogroups of pathogenic leptospires? First, the dog is
the reservoir of Canicola, whereas rodents are the
main reservoir for other serogroups, especially
Icterohaemorrhagiae. However, not all rodent species
have the same epidemiological potential in this
respect. To become a source of infection for other
animals (including humans), rodents have to become
G. Andre´-Fontaine / Veterinary Microbiology 117 (2006) 19–24 21
Fig. 1. Seroprevalence of six serogroups in 2457 positive dogs over 5 years (microagglutination test). Serogroups: IH, Icterohaemorrhagiae;
CAN, Canicola; SJ, Sejroe¨; AUS, Australis; GRIP, Grippotyphosa; AUT, Autumnalis.
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 With leptospirosis, end-organ damage usually involves the liver, kidneys, lungs, 
eyes and brain (Bharti et al., 2003). The major issue that develops, renal disease, is the 
primary cause of death in severe cases. Leptospires infect the renal tubular cells causing 
tubular dysfunction and nephritis (inflammation of the kidneys) (Levett, 2001). Liver 
issues can also occur, presenting with increased liver enzyme values, such as ALT, AST, 
and ALP (Alanine Transaminase, Aspartate Transaminase and Alkaline phosphatase, 
respectively); however, increased serum ALP and total bilirubin concentration is the most 
common clinical sign (Sykes et al., 2011). A combination of increased blood urea 
nitrogen (BUN) and serum creatinine along with increased liver values is a sign that 
leptospirosis is a probable diagnosis (Hennebelle et al., 2014).  
 In the development of disease, fever is present with shivering, muscle tenderness 
and lack of energy (Brown & Prescott, 2008). If the disease has caused renal failure, the 
dog will present with increased drinking (polydipsia), increased urination (polyuria), 
dehydration, vomiting, diarrhea, lack of appetite, lethargy, or a combination of the above 
clinical signs (Sykes et al, 2011). Blood in urine (hematuria) can also occur with 
infection. The polyuria and polydipsia can be found without azotemia (elevated levels of 
blood urea nitrogen and serum creatinine), which can be caused by decreased glomerular 
filtration rate leading to decreased concentrating ability (hyposthenuria) (Sykes et al., 
2011). However, 80 – 90% of dogs are typically found with azotemia (Sykes et al., 2011).  
 Some dogs may develop conjunctivitis or uveitis (eye inflammation) (Sykes et al., 
2011). There is also a chance of leptospiral pulmonary hemorrhage syndrome (LPHS), a 
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respiratory distress syndrome, which can cause tachypnea (rapid breathing) or dyspnea 
(labored breathing) (Sykes et al., 2011).  
 Vasculitis (inflammation of blood vessels) is another major clinical sign seen in 
animals diagnosed with leptospirosis (Plank & Dean, 2000). Vasculitis can lead to mild 
pleural effusion (fluid build-up around the heart) and also edema in the peripheral limbs. 
This is due to the vascular damage caused by the spirochetes. Overall myocardial damage 
is also seen through increased serum troponin levels.  
 
Diagnostic Tests Utilized for Leptospirosis in Canines 
 Diagnostic tests are crucial to accurately and rapidly diagnosing leptospirosis 
(Picardeau et al., 2014). According to Sykes et al. (2011), testing for leptospirosis 
requires a multitude of tests due to the variation of results throughout the course of 
infection. Three diagnostic methods will be evaluated below: Microscopic Agglutination 
Test (MAT), Polymerase Chain Reaction (PCR), and cultures (Sykes et al., 2011). 
 
Microscopic Agglutination Test (MAT) 
 The MAT is the serogroup-specific antibody test most commonly used to 
diagnose leptospirosis (Sykes et al., 2011). The MAT involves serially diluting the 
animal’s serum with live leptospiral serovars and monitoring the agglutination of 
leptospires and detection of IgG and IgM antibodies within dark-field microscopy. The 
largest serum dilution causing agglutination of 50% of the leptospires is the value 
reported for the test.  
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 Within the first week of infection, a dog may have a negative MAT (Sykes et al., 
2011). Typically, a veterinarian performs a MAT, the acute titer, when the dog is ill. The 
convalescent titer is done 2-4 weeks after the acute titer, usually once the dog is 
recovering. The recommendation to wait at least 7 to 14 days between successive titers 
allows for seroconversion, meaning that the specific antibody will then be detectable in 
the blood (Sykes et al., 2011). A titer that increased by 4-fold is often a sign of recent 
infection; however, there is the chance that if the dog is being treated with an antibiotic, 
the titer will be lower.  
 Regular vaccination can usually cause a low increase in titer values; however, 
there is a possibility that recent vaccination can increase titer values to high values, 
usually indicative of infection, such as, 1:800 or 1:1600 (Sykes et al., 2011). This can 
lead to misdiagnosis of leptospirosis when the dog is not infected; thus, it is important to 
evaluate clinical signs, utilize other diagnostic methods, and attain a proper vaccination 
history on the animal before diagnosis. Titers following a natural infection due to 
vaccination can remain elevated for 1 year, with the titers beginning to decline after 4 
months (Sykes et al., 2011). 
 Although this test is widely used and inexpensive, it does have many limitations 
(Sykes et al., 2011). The lack of sensitivity in the first week of infection may lead to fatal 
results for the animal. The test is serogroup-specific rather than serovar-specific due to 
the ability of serovars to cross-react within serogroups. This is a limitation because it 
leads to lower specificity of results. False negatives can occur because of the low number 
of serovars (5-7) included in the canine diagnostic panel.  The MAT can also be very 
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hazardous for laboratory technicians because the test involves live Leptospira strains. The 
use of dark-field microscopy also presents a limitation as it can be subjective and due to 
lack of standardization, varied results occur between different laboratories. There is also a 
lack of consensus on a titer value for a negative result. There is also a chance that the 
strains may become contaminated through serial dilutions; thus, the strain identity must 
be confirmed consistently (Sykes et al., 2011).  
Polymerase Chain Reaction (PCR)  
 PCR, a useful diagnostic method for early infection, detects the nucleic acid 
sequence of pathogenic leptospires. During the first week of infection, leptospires are 
most prevalent in the blood. After the first week, urine has the highest concentration of 
leptospires. If the time of infection is uncertain, both blood and urine may be used for 
testing. PCR is useful for animals that may show positive titer values and for early 
diagnostic testing (Sykes et al., 2011) Regular vaccination will not cause positive PCR 
results, thus this diagnostic method can help confirm positive results attained with MAT 
following vaccination.  PCR is also helpful in determining carriers of the disease because 
it will show a positive result on urine in a healthy, asymptomatic dog (Sykes et al., 2011). 
However, there are some limitations of the PCR method. PCR can give false negative 
results if the canine has been on multiple rounds of antibiotics.  Also, PCR is often unable 
to identify the serovar that causes infection, which is important information for 
understanding the epidemiology of the disease (Levett, 2001).  
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Culture 
 According to Sykes et al. (2011), cultures involve utilizing specific media to 
detect pathogenic leptospires. Due to the slow growth of leptospires, incubation is often 3 
to 6 months; thus, cultures are not helpful with early detection. Blood is typically 
examined within the first week of infection and urine is examined after the first week. 
One limitation of utilizing cultures is the chance of a false negative if the canine has been 
placed on antibiotics.   
 
Treatment for Leptospirosis in Canines 
 According to Sykes et al. (2011), treatment with antimicrobials is controversial 
when treating leptospirosis, thus many forms of treatment are utilized. However, the 
recommended antimicrobial treatment according to the ACVIM Small Animal Consensus 
for leptospirosis in canines is doxycycline, 5 mg per kg body weight by mouth or 
intravenously every 12 hours, for 2 weeks (Sykes et al, 2011). This medication should be 
administered as quickly as positive serum results are found. If doxycycline is found to 
cause gastric upset, such as vomiting or diarrhea, or other adverse side effects, ampicillin 
is the drug that should be used. Ampicillin should be given as 20 mg per kg body weight 
intravenously every 6 hours, decreasing the dose for dogs with azotemia. Ampicillin 
should only be used intravenously because it is not properly absorbed through the 
digestive tract upon oral administration. Doxycycline should be resumed two weeks after 
gastrointestinal issues subside, to ensure that all bacteria are removed from the proximal 
tubule cells (Sykes et al., 2011).  
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 Fluid therapy may be valuable for some canines; however, urine output, blood 
pressure, and lung sounds should be monitored to avoid fluid overload, a life-threatening 
effect. In cases of anuria, excretion of very little urine leading to increased BUN levels, 
dialysis may be recommended. Dogs that would benefit from dialysis usually have BUN 
levels of 80 mg/dL or above and increased serum potassium levels (Sykes et al., 2011). 
Typically 1 to 3 treatments are required before urination resumes normally, with renal 
function usually recovering 2 to 4 weeks upon beginning dialysis.  
 Dogs that develop LPHS may benefit from oxygen therapy, with more severe 
cases requiring mechanical ventilation. A particular drug to treat LPHS has not been 
indicated in dogs; for instance, dexamethasone and desmopressin have not been shown to 
improve LPHS symptoms (Sykes et al., 2011).  
 
Prevention: Efficacy of the Leptospirosis vaccine 
 Vaccination may be one important way to impede the transmission of 
leptospirosis from pets to owners. Vaccination is recommended annually with a vaccine 
containing 4-serovars, typically icterohaemorrhagiae, canicola, grippotyphosa, and 
pomona (Sykes et al., 2011). While anaphylactic reactions have been a concern with the 
leptospirosis vaccine particularly in small breeds, documented incidences have decreased 
with better vaccine developments; moreover, the vaccine has proven very effective, 
providing immunity for 12 months after vaccination (Sykes et al., 2011).  
 According to Schreiber et al. (2005), one major concern regarding Leptospirosis 
and its transmission to humans and other animals is urinary shedding. This study 
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involved vaccinating six pups with the CANIGEN ®L vaccine containing inactive strains 
L. canicola and L. icterohaemorrhagiae and comparing the findings to six pups that were 
not vaccinated for any Leptospirosis strains. Following two vaccine injections, every 
canine was introduced to the L. icterohaemorrhagiae strain through an intraperitoneal 
injection. The results showed that the six control pups were not protected against the 
strain of Leptospirosis and had positive blood and urine results. However, 5 of the 6 
control pups with positive tests did not show any significant clinical symptoms. Most 
notably, the vaccinated group showed complete immunity against the strain of bacteria 
(Schreiber et al., 2005).  
 A more recent study found similar results concerning the effectiveness of the 
Leptospirosis vaccine. Klaasen et al. (2014) examined the efficacy of a newly developed 
vaccine and its ability to attain immunity for canines over a 12-month period. The study 
involved 8 groups of 9 pups, one control group and one vaccinated group for each of the 
four strains of Leptospirosis: canicola, icterohaemorrhagiae, grippotyphosa and 
australis. The pups were vaccinated twice, four weeks apart and then housed for a year in 
an environment that prevented infection. After 12 months, the pups were challenged 
through intraperitoneal and conjunctival routes using one of the four strains. Four weeks 
following the challenge, blood, serum, and urine were all collected. As can be seen below 
in Table 3, the vaccine was able to significantly reduce the chance of infection for all 
strains and the chance of renal infection by canicola and icterohaemorrhagiae in the 
vaccinated pups. These results represent the importance of vaccination in reducing 
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urinary shedding of leptospires, thus aiding the prevention of transmission to humans and 
other species (Klaasen et al., 2014). 
 
Table 3: Number of Dogs Positive for Leptospirosis Infection and Renal Infection. 
The table provides the results comparing the control and vaccinated group. The control 
group significantly differed from the vaccinated group with all four strains, showing 
infection in the majority of pups. Renal infection was only significant between the two 
groups with the L. canicola and L. Icterhaemorhagiae strains.  Table adapted from 
Klaasen et al., 2014. 
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Table  2
Numbers of dogs positive for infection or renal infection post-challenge.
Study (challenge) Group No. of dogs/group positive for:
Infection Renal infection
No. of dogs Significant? No. of dogs Significant?
1 (Canicola) Vaccine 1/9 S (P = 0.0004) 1/9a S (P = 0.0004)
Control 9/9 9/9
2  (Icteroh.) Vaccine 0/9 S (P = 0.0091) 0/9 S (P = 0.0091)
Control 6/9 6/9
3  (Gripp.) Vaccine 1/8b S (P = 0.0152) 1/8b NS (P = 0.4706)
Control 7/9 0/9
4  (Australis) Vaccine 2/8 S (P = 0.0152) 0/8 NS (P = 0.0824)
Control 8/9 4/9
a Dog had three positive urine samples; no clinical signs, no thrombocytopania, no positive kidney, no interstitial nephritis.
b Dog had interstitial nephritis; no positive culture/PCR results, no clinical signs, no thrombocytopenia.
infection (results not shown). In the case of the Grippo-
typhosa study, challenge did not lead to detectable renal
infection in any of the control group. In contrast, a similar
challenge study in our laboratory using the same chal-
lenge (strain, method and dose) carried out in puppies at 13
weeks of age induced signs of renal infection in seven out
of eight control dogs (Klaasen et al., 2013). Apart from the
Bratislava study where a repeated challenge on two  con-
secutive days was performed, it was observed that fewer
control dogs had positive blood and or urine cultures in
the present studies involving challenge in adult dogs than
in the previously published studies with challenge in pups.
This discrepancy can be explained by the fact that adult
animals are known to have a higher resistance to infection
with pathogenic Leptospira bacteria compared to young
animals (Faine, 1994b). In the present Grippotyphosa chal-
lenge study there was also one vaccinated dog with signs of
interstitial nephritis at post-mortem but with no evidence
of the presence of leptospires (by either culture or PCR) and
no clinical signs or evidence of thrombocytopaenia (results
not shown). Although this case, according to the definition
of a dog positive for renal infection, has been scored as a
positive case it is likely that the interstitial nephritis could
have resulted from some other cause.
In these studies we were able to reproduce transient
leptospiraemia and urinary shedding of the challenge
organisms in non-vaccinated control dogs following chal-
lenge with pathogenic strains from serogroups Canicola,
Icterohaemorrhagiae and Bratislava, and transient lep-
tospiraemia for Grippo typhosa. With this vaccine urinary
shedding of leptospires is reduced, which implies that the
vaccine helps prevent transmission of the infection to other
animals and to humans and, therefore, is an aid in preven-
ting these zoonotic infections (Feigin et al., 1973).
4. Conclusion
In this study significant protective immunity was
achieved in dogs 12 months after a basic vaccination
schedule of two doses against strains of serogroups
Canicola, Icterohaemorrhagiae, Grippotyphosa and Aus-
tralis. Reduction of infection (leptospiraemia) was  demon-
strated against a Grippotyphosa strain, and reduction
of infection, renal infection and urinary shedding was
demonstrated against strains of serogroups Canicola,
Icterohaemorrhagiae and Australis.
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Leptospirosis in Humans 
 
 According to Levett (2001), leptospirosis was first thought to be initiated in 
Western Europe in the 18th century the movement of rats from Eurasia, transmitting the 
serovar icterohaemorrhagiae of Leptospira interrogans; however, it wasn’t until 1917 
that rats were recognized as the cause of infection. With the introduction of leptospirosis, 
the risk of contraction of the disease was associated with occupations. Although rodents 
are still recognized as the primary carrier of leptospirosis, increased incidence of disease 
in domestic animals provides a higher possibility of transmission to humans (Wasinski & 
Dutkiewicz, 2013).  
 Currently, according to Guerra (2013), leptospirosis is emerging globally due to 
the increased contact between humans and animals, through pet ownership, increased pet 
trade, global climate change, and human population expansion. People and animals 
forming close relationships are of significant importance in the transmission of 
leptospirosis, thus the necessity of acknowledgement of this reemerging disease. Global 
climate change, including increased temperature, can allow the leptospires to survive 
longer in the environment increasing the possibility of contracting leptospirosis. Changes 
in climate have also increased the occurrence of natural disasters, including hurricanes, 
which cause increased flooding and chance of transmission of the disease. Human 
population expansion causes the spread of people into wildlife habitats, increasing the 
chance of humans coming into contact with animals and can increase the transmission of 
leptospirosis to humans and domestic animals, wildlife, and livestock. Increased 
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urbanization of slum regions, where there is a prevalent rodent population, also increased 
the possibility of transmissions to humans (Goris et al., 2011). In addition, migration of 
people from areas of tropical climates, or areas of low economic status with decreased 
sanitation, can also increase the transmission of disease (Wasinski & Dutkiewicz, 2013).  
 
Risk Factors and Prevalence in Humans 
 According to Wasinski & Dutkiewicz (2013), although leptospirosis is definitely 
reemerging, it is often a neglected disease due to the relatively low number of 
documented cases in humans and animals in temperate climates and the improved 
therapeutic methods in these areas. Furthermore, since in the United States, only 100-200 
cases in humans were documented every year through 1994, it was no longer a notifiable 
disease in many states, except in the states with the highest incidences, such as, Hawaii, 
Texas, California, and Puerto Rico (Guerra, 2013). Nevertheless, there is an 
understanding that cases of leptospirosis go misdiagnosed and thus cause a lower annual 
number of cases (Levett, 2001).   
 Before 1970 in the United States, many documented cases of leptospirosis had 
occupational origins, in farmers, veterinarians, miners, military personnel, and sewage 
and agricultural workers; however, due to protective measures, these incidences have 
decreased (Bharti et al., 2003). Many outbreaks have also been associated with drinking 
infected water and working with rodents (Levett, 2001). Infection can also occur even in 
recreational settings, particularly in developed countries (Levett, 2001). Swimming, 
kayaking, and fishing are thought to be three major outdoor sports that increase the risk 
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of contracting leptospirosis (Brown & Prescott, 2008). Recent outbreaks in the United 
States have occurred with participants in triathlons, involving water events (Guerra, 
2013). The risk of infection increases with activities in stagnant bodies of water, that 
allow the leptospires to survive (Sykes et al., 2011). Also, with increasing travel to 
tropical climates and internationally, leptospirosis risk has increased as a recreational 
disease (Hartskeerl et al., 2011). Prevalence of disease also increases with lower 
socioeconomic status due to the increased rodent infestations (Guerra, 2013).  
 
Manifestations of Leptospirosis in Humans  
 According to Levett (2001), humans that are infected with leptospirosis 
experience a broad range of symptoms depending on the infecting serovar. The majority 
of cases that occur in humans fall under the anicteric form of mild severity, with patients 
often not even seeking medical attention. Symptoms are similar to those seen in animals, 
often presenting as fever, chills, headache, abdominal discomfort, conjunctivitis, and 
myalgia (muscle pain). There may also be skin rashes present, lasting the first week of 
infection, and diminishing upon increased levels of antibodies. Typically mortality is low 
in these mild cases; however, in an outbreak in China, pulmonary hemorrhage was a 
cause of death in 2.4% of the cases (Bharti et al., 2003).  
 The most severe form of leptospirosis in humans is known as Weil’s syndrome, 
the icteric form typically caused by the serovars of serogroup icterohaemorrhagiae, and 
makes up 5-10% of cases (Levett, 2001). Leptospirosis is a disease that can affect many 
critical organs (Rajapakse, Rodrigo, Balaji, & Fernando, 2015).The typical findings in 
 46 
this severe form include jaundice, acute renal failure, myocarditis, conjunctival suffusion 
(swelling and redness, without discharge), aseptic meningitis, and hemorrhage . 
According to Bharti et al. (2003), the jaundice that occurs in leptospirosis is not due to 
hepatocyte damage but rather due to the blockage of conjugated bilirubin into the bile 
canaliculi. The sodium-potassium pumps that provide the energy for bilirubin secretion 
become dysfunctional, leading to increased serum bilirubin levels.  
 The mortality rate of icteric leptospirosis is relatively high at 5-15% (Levett, 
2001). According to Rajapakse et al. (2015), the typical fatal complications include: renal 
failure, myocarditis, and pulmonary hemorrhage. Renal failure can be fatal in humans 
due to uremia (increased urea in blood), acidosis, hyperkalemia, or pericarditis. Renal 
failure is typically caused by leptospires adhering to the tubule cells of the proximal 
nephron. However, renal failure is not always a cause for mortality. In 16-40% of cases, 
acute renal failure without oliguria (low urine output) has been documented, with oliguria 
used as a predictor of fatality (Bharti et al., 2003). Myocarditis can lead to death due to 
the manifestations of hypotension and arrhythmias; furthermore, it can be worsened 
through renal failure, with fluid overload and pericarditis (Rajapakse et al., 2015). 
Respiratory manifestations of pulmonary hemorrhage can lead to dyspnea or hemoptysis 
(coughing up blood) (Rajapakse et al., 2015). With severe respiratory complications, 
there is a case fatality risk of 70% (Goris et al., 2011). 
 Although there are not many reported case, leptospirosis in pregnant individuals 
has been shown to cause miscarriages, stillbirths, and post-partum sepsis (Rajapaske et 
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al., 2015). There is also a possibility that the mother is able to pass on the bacteria 
through the placenta and breast milk (Rajapaske et al., 2015).  
 
Testing for Leptospirosis in Humans 
 According to Goris et al. (2011), due to the major risks of leptospirosis, timely 
diagnosis is very important in ensuring proper treatment and preventing the possibility of 
fatality. However, the lack of sufficient diagnostic tests contributes to the 
underestimation of leptospirosis (Picardeau et al., 2014). Testing for leptospirosis in 
humans is very similar to that of testing in animals. The MAT is also used to examine the 
titer level of leptospires found in the patients’ blood. However, just as in canines, the 
MAT is disadvantageous in early detection because of the lack of antibodies found in 
blood until 5 to 10 days after infection occurs. Cultures can also be done on blood, 
cerebral spinal fluid, and urine within 10 days of onset. However, as in canines, 
leptospires are very slow growing and thus results take approximately 4 months and lack 
sensitivity. PCR is also utilized in combination with MAT and cultures; however, it is 
considered too complicated and expensive (Goris et al. 2011).   
 The most common tests utilized for early detection include the enzyme linked 
immunosorbent assay (ELISA) and IgM dipstick assay, both requiring approximately 2-4 
hours and utilizing blood samples. The ELISA, typically sent to outside laboratories, 
detects anti-Leptospira antibodies earlier than MAT; however, positive results of ELISA 
should be confirmed through MAT, culture, or PCR (Picardeau et al., 2014). IgM 
antibodies typically appear 4-5 days after onset of disease, thus allowing the IgM dipstick 
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assay, an in-house diagnostic tool, to be considered earlier detection that MAT, PCR, and 
culture (Picardeau et al., 2014). 
 According to Picardeau et al. (2014), the future of diagnostic testing for 
leptospirosis should involve tests that incorporate multiple mediums, allowing for 
differential diagnosis between two diseases. These multiplex diagnostic tools would be 
valuable particularly in tropical environments where diseases share many common 
symptoms with leptospirosis, such as dengue. These rapid diagnostics have become a 
priority of the Global Leptospirosis Environmental Action Networks (GLEAN), 
developed by WHO, to decrease the risk and prevalence of outbreaks of leptospirosis.  
 
Treatment for Leptospirosis in Humans  
 Like in canines, antimicrobial use is controversial, however, when a diagnosis is 
positive for leptospirosis, medical professionals will often prescribe antibiotics (Bharti et 
al., 2003). According to the Cochrane review, there was not enough data on the 
effectiveness of antibiotics in treating leptospirosis to provide the appropriate treatment 
practice (Brett-Major & Coldren, 2012). Despite the lack of evidence of the effectiveness 
of antibiotic therapy, doxycycline, cephalosporins, and penicillin are the three most 
widely used antibiotics for leptospirosis (Brett-Major & Coldren, 2012). These antibiotics 
are most successful in the treatment of leptospirosis when given early in the course of 
infection (CDC, 2015). Furthermore, with severe cases, high doses of intravenous 
penicillin is typically recommended; while in less severe cases, oral antibiotics of 
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amoxicillin, ampicillin, erythromycin, or doxycycline can be prescribed (Hartskeerl et al., 
2011). 
 Leptospirosis treatment often requires fluid therapy to ensure proper fluid volume, 
blood pressure, and electrolyte balance (Gulati & Gulati, 2012). Dialysis and blood 
transfusions may be appropriate for patients with severe renal dysfunction and 
hemorrhage (Gulati & Gulati, 2012). According to Hartskeerl et al. (2011), dialysis has 
been shown to be effective in decreasing the rate of fatality. 
  In severe cases involving pulmonary complications, corticosteroids can be a 
useful form of treatment if given within 12 hours of pulmonary symptoms (Shenoy, 
Nagar, Chowdhury, Bhalgat, & Juvale, 2006). One case study also found improvement of 
all major organs in a severe case of leptospirosis with 500 mg of methylprednisolone in 
combination with intravenous IgG antibodies (Meaudre et al., 2008)    
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Global Impact of Leptospirosis 
 
 Leptospirosis is recognized as a global issue, emerging in developing and 
developed countries alike (Dupouey et al., 2014). Due to the common misdiagnoses and 
lack of knowledge regarding the transmission leptospirosis, the number of cases globally, 
350,000 to 500,000 cases annually, is thought to be an under-estimation (Hartskeerl et al., 
2011).  With tropical countries, such as South East Asia and Latin America, having the 
highest incidence of leptospirosis and also many tourists, risks of the disease being 
dispersed globally are prevalent (Hartskeerl et al., 2011). Other areas that have found 
increases incidences of leptospirosis, include Europe, especially throughout certain parts 
of France (Dupouey et al., 2014). 
 
Reemergence of Leptospirosis in Europe 
 According to Dupouey et al. (2014), the number of cases throughout many 
European countries has remained low, with 0.13/100,000 cases occurring per year and in 
2010, a total of 588 cases occurring in 25 European countries. Although, the incidences 
have remained relatively stable, the highest incidences occur in these five European 
countries: France (0.37/100,000 inhabitants), Romania (0.84/100,000), Slovakia 
(0.50/100,000), Slovenia (0.44/100,000), and the Czech Republic (0.38/100,000).  In 
France, cases of leptospirosis are reported voluntarily, thus leading to an underestimation; 
nevertheless, France, including its overseas territories, has the highest endemic numbers 
in Europe, with the disease mainly associated with occupations, such as sewers workers 
 51 
and fish farming. Increased rat populations have been thought to be the reason for this 
higher incidence in France. Furthermore, travel to Europe may be involved in 33% of the 
leptospirosis cases, typically due to recreational activities, such as water sports. In 
Germany, a study done to determine the cause of exposure in 102 leptospirosis cases 
between 1997 and 2000, found that 30% of incidences were related to occupation, 30% to 
recreational activities, and 37% occurred near residential areas (Wasinski & Dutkiewicz, 
2013). Of these incidences, 31% involved human contact with rats and dogs.  
 Although the values of incidence of leptospirosis have not increased greatly in 
Europe, the large prevalence of mild leptospirosis and misdiagnosed cases presents an 
important issue. Furthermore, the fact that leptospirosis is found globally is a sign that the 
bacteria are viable in many environments. With the changes in climate and increased 
rodent populations, the risk of leptospirosis may increase in the following years; thus, 
leptospirosis may become a more prominent issue in European countries as well 
(Dupouey et al., 2014).  
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Public Health Implications of Leptospirosis 
 
 Leptospirosis is recognized as a public health concern due to the increasing global 
incidence (Guerra et al., 2013). Since disease in wildlife cannot be completely eliminated, 
there is constant risk of domestic animals contracting infection (Brown & Prescott, 2008). 
The risk of humans contracting disease from these infected domestic pets is low; 
however, they continue to pose a risk and, thus protective measures should be utilized 
(Brown & Prescott, 2008). Vaccination is one prevention measure shown to provide 12-
month immunity and eliminate renal shedding in canines, but other protective measures 
are also necessary to limit transmission of disease in cases of infected animals. Because 
the epidemiology of leptospirosis is dynamic, and cases are underreported, understanding 
the prevention of disease in humans is not clearly documented; however, there are many 
ways that transmission of disease can be decreased (Hartskeerl et al., 2011).  
 In the presence of an infected animal, prevention is thought to be achieved using 
protective clothing, such as gloves and boots (Hartskeerl et al., 2011).  According to 
Sykes et al. (2011), the animal with symptoms similar to that of leptospirosis should be 
handled cautiously in a hospital setting. For instance, movement around the hospital 
should be minimal and all areas the animal comes into contact with should be disinfected. 
It is also very important that immunocompromised and pregnant individuals avoid all 
contact with suspected infected animals. The suspected canine should have a restricted 
area to urinate and that area should be disinfected. If the canine urinates on itself, the hair 
should be bathed immediately so that no one comes into contact with it.   
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 According to Hartskeerl et al. (2011), risk of transmission from domestic animals 
can be reduced by vaccination. While vaccines are available for dogs, cattle, and pigs, it 
is important to note that vaccination will not completely prevent transmission of 
leptospirosis, but rather reduce the shedding of leptospires. Human vaccines are limited 
and are only utilized in China, France, Russia, and Cuba.  
 According to Sykes et al. (2011), education is very important in decreasing the 
risk of leptospirosis transmission. Pet owners should understand the transmission of 
leptospirosis, the risks of the disease for their pets and their families, the common 
symptoms that may occur, and the importance of vaccination of their animals. 
Veterinarians should discuss how canines can contract leptospirosis from the urine of 
wild and farm animals, providing prevalent risk factors.   
 
Importance of One Health 
 According to Cantas & Suer (2014), communication among all medical 
practitioners is important in providing support to public health and reducing the 
transmission of zoonotic diseases. “One Health” is the idea that interactions occur 
between pathogens, animals, and humans sharing a certain environment. This approach is 
important is limiting the transmission of zoonotic diseases by emphasizing the 
importance of communication among all medical practitioners, veterinarians, and public 
health advocates. For instance, medical practitioners can often lack awareness regarding 
the common zoonoses surrounding household pets; thus, communication between 
veterinarians and medical practitioners would be beneficial, allowing medical 
 54 
practitioners to be aware of early symptoms of diseases and also educate clients about 
these common zoonoses to limit the transmission of disease (Damborg et al., 2015).  
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DISCUSSION AND FUTURE DIRECTIONS 
 
 Leptospirosis has been viewed as a neglected zoonotic disease, especially in 
tropical climates. The disease has the potential to be extremely dangerous through its 
manner of transmission and its relatively high fatality rate. The major goals of this thesis 
have been to acknowledge the increasing risk of leptospirosis and understand the disease 
from the perspective of canines and humans. With the increasing prevalence of canines in 
households particularly in the United States, there are higher risks of major carriers of 
leptospirosis for other animals and the people that care for them. Through fully reviewing 
the biology, transmission, testing, and treatment protocols, we can better examine ways to 
limit the transmission of disease and prevention of future outbreaks.  
 One important aspect of limiting the chances of transmission of leptospirosis from 
domestic pets to humans is client education. Education requires that veterinarians, 
veterinary technicians, and even medical practitioners take time to review the common 
zoonoses with their clients and patients so that they become aware of the risks and take 
precautions. Medical practitioners may then be more aware of the early symptoms of 
leptospirosis, thus potentially allowing for the report of leptospirosis cases to be more 
accurate. Furthermore, with more accurate reporting of cases, a better understanding of 
proper treatment protocols can be developed, as right now antimicrobials are 
controversial and there is not one specific treatment plan identified. Veterinary schools 
should also implement courses focused mainly on zoonotic diseases and how to properly 
provide pet owners with valuable information to diminish the risks of transmission 
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(Bingham et al., 2010). In addition, veterinarians could emphasize to clients the 
importance and necessity of vaccination and the risks of leptospirosis, especially in 
regions of humid climates and also for canines most at risk, such as working dogs.  
 Limiting the transmission of leptospirosis is a major component in preventing 
future outbreaks. Future work in the further understanding of leptospirosis should focus 
on development of diagnostic tests that provide immediate results and allow for 
comparison between multiple diseases. Also, since vaccination in animals seems like a 
necessity in preventing the renal shedding of leptospires, thus limiting the transmission of 
disease, more widespread vaccination of humans should be taken into consideration. 
Thus, the development of vaccines containing the common serovars that are most 
common in humans, particularly in areas of warmer climates, such as Hawaii and western 
United States, may be beneficial to impede the transmission of disease and prevent future 
outbreaks.  
 Another area of further research could involve the mechanisms of katE in a 
possible treatment. KatE prevents the oxidative breakdown of leptospires. If a treatment 
could potentially down-regulate this enzyme, there could be potential for the body to 
digest the pathogenic strains of Leptospira more rapidly; however, this would require that 
the disease be confirmed early, which would necessitate reliable and rapid diagnostic 
tools for early diagnosis. This could also help reduce the use of antimicrobials, thus 
mitigating the chance of further resistance of antibiotics. 
 With further research into leptospirosis and increased recognition of the disease, 
we may be better able to reduce the risk of transmission to humans. Through limiting the 
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transmission from domestic pets through the use of vaccines, this will limit the amount of 
transmission through renal shedding to other animals. However, due to the prevalence of 
wild animals and their endemic infection, vaccination of household pets will only help to 
limit the transmission and not fully eliminate transmission. Thus, vaccination for humans 
and proper recognition of the disease will play a huge role in limiting the transmission of 
disease in the future.     
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